Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Hospital Charity Care
  • Single-Payer Healthcare
  • TrumpRx
  • Pharmacy Discount Coupons
  • Decoding Health Insurance Terms

WHAT'S NEW

  • Hospital Charity Care
  • Single-Payer Healthcare
  • TrumpRx
  • Pharmacy Discount Coupons
  • Decoding Health Insurance Terms

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 8 2021

Full Issue

More States Have Cleared The Way For Purdue Pharma's Bankruptcy Plan

Fifteen states have dropped their objections to the OxyContin maker's reorganization plan, moving the company closer to transforming itself into a new entity that helps combat the opioid epidemic through its own profits, AP reported.

NPR: 15 States Drop Opposition To Controversial Purdue Pharma Oxycontin Bankruptcy

Fifteen states that led the effort to block a controversial bankruptcy plan for Oxycontin-maker Purdue Pharma have abandoned the fight. That's according to court documents filed by a mediator late Wednesday night as part of a federal bankruptcy proceeding in White Plains NY. Among the states that have agreed to sign on to the bankruptcy deal are Massachusetts and New York, whose attorneys general had mounted fierce legal opposition to the deal. (Mann, 7/8)

AP: More States Agree To Settlement Plan For Opioid-Maker Purdue

More than a dozen states have dropped their longstanding objections to OxyContin maker Purdue Pharma’s reorganization plan, edging the company closer to resolving its bankruptcy case and transforming itself into a new entity that helps combat the U.S. opioid epidemic through its own profits. The agreement from multiple state attorneys general, including those who had most aggressively opposed Purdue’s original settlement proposal, was disclosed late Wednesday night in a filing in U.S. Bankruptcy Court in White Plains, N.Y. It followed weeks of intense mediations that resulted in changes to Purdue’s original exit plan. (Mulvihill, 7/8)

In other news about the opioid epidemic —

TechCrunch: Opioid Addiction Treatment Apps Found Sharing Sensitive Data With Third Parties

Several widely used opioid treatment recovery apps are accessing and sharing sensitive user data with third parties, a new investigation has found. As a result of the COVID-19 pandemic and efforts to reduce transmission in the U.S, telehealth services and apps offering opioid addiction treatment have surged in popularity. This rise of app-based services comes as addiction treatment facilities face budget cuts and closures, which has seen both investor and government interest turn to telehealth as a tool to combat the growing addiction crisis. (Page, 7/7)

AP: Evers Defends His Signing Of Opioid Bill Despite Concerns

Gov. Tony Evers on Tuesday defended signing a bill that he believes is partially unconstitutional and that every Democrat except one in the Legislature opposed, saying the measure will speed disbursement of settlement money with opioid manufacturers. Evers’ decision to sign drew bipartisan praise at a news conference Tuesday in Waukesha, from Republican Waukesha County Executive Paul Farrow and Democratic Milwaukee County Executive David Crowley. (Bauer, 7/6)

NPR: Overdoses Involving Cocaine And Fentanyl Are On The Rise

On a recent Thursday evening, three dozen people gathered in the backyard at Nowadays, a trendy club in Queens, N.Y., to learn how to use naloxone, a nasal spray that reverses overdoses from opioids. The training was organized by a group of nightlife and health care professionals called Last Night A DJ Saved My Life. Some in attendance showed up because they had seen posts on social media saying that fentanyl, a synthetic opioid that's about 50 to 100 times more potent than morphine, was being cut into cocaine, putting unsuspecting party goers at risk. (Lewis, 7/7)

AP: Mom Complains Of Suboxone In Son's McDonald's Happy Meal Box

Police have charged two Maine people with drug crimes after a mother complained that she found a medication used to treat opioid use disorder in her son’s Happy Meal box at McDonald’s. Auburn police said Wednesday they reviewed video surveillance footage and concluded the incident was the result of an accident by an employee. They said the employee had the medication, Suboxone, in a shirt pocket and bent over to retrieve something when it fell out, landing in the Happy Meal box. (7/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 11
  • Friday, May 8
  • Thursday, May 7
  • Wednesday, May 6
  • Tuesday, May 5
  • Monday, May 4
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF